Alzheimer Disease: New Target Structure for the Development of Pharmaceuticals
At present about 18 million people worldwide suffer from Alzheimer disease, a neurodegenerative disorder which leads to dementia. The pharmaceuticals currently registered for the treatment of Alzheimer are only able to reduce symptoms marginally and delay progression of Alzheimer disease to a limited extent. The novel preventive target structure, the APP-AICD/ Fe65-PTB2 complex, offers a new chance for the development of a possible pharmaceutical for a causal treatment of Alzheimer disease.
Further information: PDF
Technologie-Lizenz-Büro (TLB) der Baden-Württembergischen Hochschulen GmbH
Phone: +49 (0)721/79 00 40
Contact
Dipl.-Biol. Marcus Lehnen, MBA
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles

High BTMPS Levels Found in Fentanyl: What It Means for Safety
A UCLA research team has found that drugs being sold as fentanyl contain high amounts of the industrial chemical bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate, or BTMPS. This new substance of concern emerged in…

Gas Adsorption Insights on Platinum and Gold Nanotunnels
Understanding gas diffusion in nanoscale voids key to new gas technologies Tokyo, Japan – Researchers from Tokyo Metropolitan University have elucidated how hydrogen and carbon monoxide is adsorbed into solids…

Pandemic Resilience: How Playfulness Boosted Well-Being
Adults with high levels of playfulness showed strong resilience during the COVID-19 pandemic compared to less playful individuals, new research shows. The study led by Xiangyou “Sharon” Shen of Oregon…